
CAS 2323027-38-7
:Ordinare per
Purezza (%)
0
100
|
0
|
50
|
90
|
95
|
100
6 prodotti.
N-(1-(2,4-Bis(trifluoromethyl)benzyl)-1H-pyrazol-4-yl)-5-(furan-2-yl)isoxazole-3-carboxamide
CAS:Formula:C20H12F6N4O3Purezza:99%Colore e forma:SolidPeso molecolare:470.3247Ref: IN-DA01KK9E
250mgPrezzo su richiesta1mg75,00€5mg114,00€10mg177,00€25mg242,00€100mg511,00€50mg514,00€N-(1-(2,4-Bis(trifluoromethyl)benzyl)-1H-pyrazol-4-yl)-5-(furan-2-yl)isoxazole-3-carboxamide
CAS:N-(1-(2,4-Bis(trifluoromethyl)benzyl)-1H-pyrazol-4-yl)-5-(furan-2-yl)isoxazole-3-carboxamidePurezza:99%Peso molecolare:470.32g/molCeapin-A7
CAS:Ceapin-A7 blocks ATF6α during ER stress, IC50 at 0.59 μM, useful for studying ATF6α mechanisms and disease roles.Formula:C20H12F6N4O3Purezza:99.5% - 99.74%Colore e forma:SolidPeso molecolare:470.32N-(1-(2,4-Bis(trifluoromethyl)benzyl)-1H-pyrazol-4-yl)-5-(furan-2-yl)isoxazole-3-carboxamide
CAS:Purezza:99%Peso molecolare:470.3309937Ceapin-A7
CAS:Ceapin-A7 is a small molecule inhibitor, which is derived from chemical synthesis, targeting the ATF6 arm of the unfolded protein response (UPR). It functions by selectively inhibiting ATF6α signaling, a critical pathway activated during endoplasmic reticulum (ER) stress. The mode of action involves binding to ATF6α, preventing its transport to the Golgi apparatus, and thereby inhibiting its subsequent cleavage and activation.Formula:C20H12F6N4O3Purezza:Min. 95%Peso molecolare:470.3 g/mol




